Fact-checked by Grok 2 weeks ago

Emotional lability

Emotional lability, also known as labile affect, refers to rapid, exaggerated, and often uncontrollable shifts in or that are disproportionate to the triggering event or circumstance. These changes typically involve intense episodes of laughing, , , or anger that arise suddenly and may persist briefly before shifting again, distinguishing it from typical mood variability. While emotional lability is a broad symptom encompassing instability in various contexts, it includes specific neurological manifestations such as (PBA). Unlike deliberate emotional responses, lability stems from disruptions in the brain's regulation of affect, leading to expressions that feel involuntary and embarrassing to the individual. This condition frequently manifests as a symptom of underlying neurological or psychiatric disorders rather than a standalone . Common causes include injuries such as (TBI), , or (MS), which damage pathways in the frontal lobes or responsible for emotional control. It is also associated with psychiatric conditions like attention-deficit/hyperactivity disorder (ADHD), , and , as well as neurological conditions like PBA, where amplifies mood instability. In ADHD, for instance, emotional lability correlates with core symptoms of and inattention, exacerbating functional impairments in daily life. Symptoms often include uncontrollable or in inappropriate contexts, heightened , rapid mood swings from to despair, and physical restlessness, which can significantly impact social relationships, work, and overall quality of life. Management of emotional lability focuses on addressing the root cause while employing symptomatic relief and coping strategies. Treatments may involve medications such as antidepressants (e.g., selective serotonin reuptake inhibitors or tricyclics) or FDA-approved agents like dextromethorphan-quinidine for PBA-related cases to stabilize mood and reduce outburst frequency. , including cognitive-behavioral techniques, practices, and emotional regulation training, helps individuals recognize triggers and develop self-soothing methods like deep or environmental adjustments. In many cases, symptoms improve with time post-injury or through targeted interventions for comorbid conditions, though ongoing support from healthcare providers and loved ones is essential for long-term adaptation.

Definition and Characteristics

Definition

Emotional lability refers to rapid, exaggerated, and often uncontrollable shifts in or that are disproportionate to the stimulus or context. This condition involves unstable emotional experiences and frequent changes, where emotions are easily aroused, intense, and do not align with the provoking events or circumstances. The term emotional lability originated in in the late within contexts, with one of the earliest descriptions provided by Pierre Marie in 1892 in relation to . Subsequent uses in the early 20th century expanded its application to various neurological disorders, emphasizing involuntary emotional outbursts. Emotional lability differs from normal emotional variability in its involuntary and intense nature, as these shifts occur without conscious control and are often excessive or unpredictable relative to the situation. Core components include affective instability, emotional incontinence, and , which are frequently used as synonyms to describe this . It is commonly associated with neurological conditions like , where such arises from brain injury.

Key Characteristics

Emotional lability is characterized by rapid and unpredictable shifts in mood, often transitioning from states of to profound or within minutes. These mood swings can occur multiple times a day and are typically triggered by minor events or without any apparent stimulus, distinguishing them from more gradual emotional changes in typical affective experiences. Individuals with emotional lability frequently exhibit inappropriate emotional responses that do not align with the context, such as sudden laughter during serious or sad situations or uncontrollable crying in response to neutral or positive stimuli. These outbursts are often involuntary and disproportionate, leading to expressions that seem mismatched to the individual's internal feelings or the social environment. For instance, in conditions involving pseudobulbar affect—a specific manifestation of emotional lability—episodes of crying or laughing can emerge suddenly without emotional congruence. The emotions experienced during these episodes tend to be more intense than in standard variations, reaching extreme levels of , , or distress, yet they are usually shorter-lived, often resolving within 15 to 20 minutes. This pattern of heightened intensity combined with brevity creates a volatile emotional that contrasts with the sustained duration of emotions in non-labile states. Such unpredictability significantly impairs social functioning, frequently resulting in , misunderstandings, or conflicts in interpersonal relationships due to the sudden and intense nature of the emotional displays. Individuals may withdraw from social interactions to avoid these episodes, exacerbating and straining personal connections. Research indicates that elevated emotional lability correlates with poorer overall social outcomes, including difficulties in maintaining or .

Causes and Risk Factors

Neurological Causes

A common neurological manifestation of emotional lability is (PBA), which arises from neurological damage that disrupts the regulation of emotional expression. Primary conditions include , (TBI), (MS), and (ALS). In , emotional lability occurs due to lesions in the or subcortical structures, with rates up to 28% in acute phases, particularly following right-hemisphere infarcts that impair emotional control circuits. TBI similarly leads to lability through or contusions, affecting up to 50% of severe cases and contributing to long-term behavioral dysregulation. MS and ALS, as progressive neurodegenerative diseases, trigger lability via demyelination or degeneration impacting bulbar pathways, with reported frequencies of 10-49% in MS and up to 50% in ALS patients, often correlating with disease severity. The core pathophysiology involves disruption of frontal-subcortical circuits, where the fails to inhibit activity, resulting in disinhibited emotional responses. Damage to these pathways, including the and , impairs the voluntary control of affective displays, leading to involuntary outbursts disproportionate to internal feelings. In , a specific mechanism entails bilateral lesions in the corticobulbar tracts, which normally modulate emotional centers; such damage causes "emotional incontinence" by releasing subcortical emotional generators from cortical restraint. Neuroimaging studies confirm atrophy in these regions, with showing particular involvement of the and cerebellar connections that exacerbate affective . Unique neurological risk factors heighten susceptibility, including age-related vascular changes that predispose to ischemic in older adults, a history of head trauma increasing TBI odds, and the progressive nature of neurodegenerative conditions like and that cumulatively impair neural integrity over time. These factors underscore the organic, lesion-based etiology distinct from psychiatric origins.

Psychiatric and Other Causes

Emotional lability is prominently associated with several psychiatric disorders, where it manifests as rapid and intense mood shifts that impair daily functioning. In , affective lability persists even during euthymic periods, serving as a marker that predicts functional impairment and social difficulties. Similarly, features marked emotional instability, characterized by frequent, intense mood changes that are easily triggered and difficult to modulate, contributing to interpersonal challenges. Attention-deficit/hyperactivity disorder often includes emotional dysregulation in 25-70% of cases, with lability linked to heightened and that exacerbates core ADHD symptoms. Post-traumatic stress disorder involves emotional lability particularly in anxiety, , and , where trauma-related cues provoke unstable affective responses. Beyond psychiatric conditions, hormonal imbalances contribute to emotional lability through disruptions in neuroendocrine . During , declining levels lead to mood instability and emotional volatility, with perimenopausal fluctuations heightening vulnerability to affective swings. disorders, such as or , induce emotional lability via altered thyroid hormone effects on systems, resulting in symptoms like irritability and mood variability that resolve with hormonal correction. , particularly during , precipitates acute emotional lability; alcohol cessation triggers irritability and dysphoric mood shifts due to GABA-glutamate imbalance, while from substances like amphetamines causes profound fatigue, , and affective instability. In children, developmental factors such as early maltreatment foster emotional lability through impaired trajectories, leading to persistent negativity and internalizing problems. The underlying mechanisms of emotional lability in these contexts involve dysregulation of key pathways and maladaptive learning processes. Imbalances in serotonin and systems, which modulate reward, , and affective , underlie mood instability across psychiatric and hormonal etiologies, with serotonin deficits promoting and fluctuations amplifying reactivity. contributes via learned emotional responses, where repeated exposure to adversity conditions heightened sensitivity to negative stimuli, reinforcing patterns of affective volatility. Risk factors for emotional lability in psychiatric and other causes include genetic predispositions and environmental stressors. Heritability estimates for mood instability range from 40-60%, with polygenic variants in genes increasing susceptibility to . Environmental influences, such as childhood abuse or , heighten risk by altering stress response systems and promoting maladaptive emotional patterns. These factors contrast with neurological origins, which typically involve structural brain lesions rather than functional or experiential disruptions.

Symptoms and Presentation

Common Symptoms

Emotional lability is characterized by frequent, involuntary, and uncontrollable outbursts of emotion that are exaggerated or disproportionate to the individual's actual mood or situation, including laughing, , , or . These episodes often occur suddenly, distinguishing them from typical emotional responses. In addition to affective displays, individuals may experience sudden spikes in , outbursts, or anxiety that arise rapidly and subside quickly, often feeling overwhelming and difficult to regulate. The frequency and duration of episodes vary depending on the underlying condition. In neurological forms such as associated with , episodes typically last from seconds to several minutes and can occur multiple times per day in severe cases. This pattern underscores the disruptive nature of emotional lability, as the brevity of each event belies its cumulative impact on daily functioning.

Clinical Presentation

Emotional lability presents with distinct variations across age groups, often proving more overtly disruptive in children than in adults. In children and adolescents, particularly those with conditions like ADHD or trauma-related disorders, it commonly manifests as intense temper tantrums, , and rapid mood swings that interfere with daily functioning, leading to heightened peer rejection and academic underperformance. For instance, preschoolers aged 4–8 years exhibit pronounced emotional instability and loss of temper, exacerbating family dynamics and social withdrawal due to frequent outbursts. In contrast, adults with emotional lability, frequently observed in severe mental disorders such as , experience subtler yet pervasive shifts like sudden or affective fluctuations that disrupt workplace interactions and contribute to occupational instability. The social and occupational repercussions of emotional lability are substantial, fostering strains, , and professional setbacks across demographics. Individuals may face interpersonal conflicts, diminished networks, and heightened risk of job loss owing to perceptions of unreliability or volatility during emotional episodes. In children, this translates to impaired family and peer relations alongside reduced adaptive skills, while adults encounter broader functional impairments in and , amplifying overall distress. These impacts can perpetuate a cycle of avoidance and further , particularly when outbursts lead to or misunderstanding in social settings. Comorbid physical features often accompany emotional lability episodes, including autonomic signs such as physiological reactivity, and in neurological contexts like , involuntary facial expressions during disproportionate laughing or crying outbursts. These manifestations, unrelated to internal emotional states, can intensify the episode's intensity and contribute to secondary anxiety or . Emotional lability shares features with , where involuntary emotional displays occur in neurological conditions.

Diagnosis and Assessment

Diagnostic Criteria

Emotional lability lacks a standalone diagnosis in the and is instead identified as a symptom cluster within broader neurological or psychiatric contexts. It is typically diagnosed when manifests as a distinct secondary to an underlying condition, rather than as an isolated primary disorder. Pseudobulbar affect (PBA) and involuntary emotional expression disorder (IEED) represent specific neurological manifestations of emotional lability, characterized by involuntary emotional outbursts. From a neurological perspective, requires of a relevant neurological history, such as , , or , alongside frequent involuntary emotional outbursts like sudden, uncontrollable laughing or crying that are disproportionate or incongruent to the patient's actual mood. For PBA-associated cases, these episodes must meet thresholds of at least two occurrences per week persisting for over a month, resulting in notable distress or functional impairment in social, occupational, or personal domains. Severity can be quantified using tools like the Pathological Laughter and Crying Scale (PLACS), where scores of 13 or higher indicate clinically significant pathological emotional expression supporting the . In psychiatric contexts, such as attention-deficit/hyperactivity disorder (ADHD), , or (), emotional lability is diagnosed as an integral feature of the primary disorder per criteria, without requiring specific frequency thresholds for outbursts. It is identified through clinical evaluation of patterns like rapid mood shifts, , or contributing to functional impairment. Differential diagnosis emphasizes excluding primary mood disorders through comprehensive clinical history and direct of episodes, as lability features brief (seconds to minutes), paroxysmal outbursts unrelated to prevailing , in contrast to the sustained, mood-congruent symptoms of conditions like or . This process ensures that comorbid psychiatric issues do not account for the presentation, confirming the neurological basis of the lability where applicable.

Assessment Methods

Clinical assessment of emotional lability typically begins with structured interviews that explore the frequency, triggers, duration, and functional impact of emotional episodes. In neurological contexts, particularly those linked to PBA, clinicians often employ self-report scales such as the Center for Neurologic Study-Lability Scale (CNS-LS), a 7-item that quantifies the extent of involuntary laughing and on a 5-point , with scores ranging from 7 to 35; a score of 13 or higher suggests significant lability. This tool, originally developed for patients with , has been validated for use in and other neurological conditions, allowing for rapid screening during routine consultations. Interviews also probe for discrepancies between emotional expression and internal mood, helping to contextualize episodes within the patient's daily life. For psychiatric presentations, assessment incorporates disorder-specific tools, such as the Affective Lability Scale-Short Form (ALS-SF), which measures dimensions of mood instability including anxiety-depression swings and anger fluctuations on a 5-point scale, to evaluate severity within conditions like or . In ADHD, rating scales like the Conners' Adult ADHD Rating Scales may capture alongside core symptoms of inattention and . Neurological examinations play a crucial role in identifying underlying brain pathology associated with emotional lability, particularly in cases linked to . Magnetic resonance imaging (MRI) and computed tomography (CT) scans are commonly utilized to detect lesions or damage in corticobulbar tracts, , or frontal-subcortical regions that may disrupt emotional regulation. These imaging modalities provide visual evidence of structural abnormalities, such as infarcts or demyelination, which inform the neurological basis of symptoms without relying solely on behavioral reports. To differentiate emotional lability from primary mood disorders like , incorporates standardized questionnaires such as the Beck Depression Inventory-II (BDI-II), a 21-item self-report measure assessing depressive symptom severity over the past two weeks, with scores categorized from minimal (0-13) to severe (29-63). Elevated BDI-II scores indicate sustained low mood congruent with , whereas high CNS-LS scores alongside lower BDI-II results point toward neurologically driven lability rather than psychiatric . This comparative approach ensures that emotional outbursts are not misattributed to primary affective disorders. Observation protocols enhance assessment by capturing real-time emotional expressions for detailed analysis. Clinicians may use video recordings of patient interactions to evaluate the incongruence between facial expressions, vocalizations, and contextual stimuli, noting the abrupt onset, brevity, and lack of voluntary control in episodes. Such recordings, often integrated into research or specialized clinical settings, allow for objective review of physiological responses like skin conductance alongside behavioral markers, distinguishing pathological lability from voluntary emotional displays.

Treatment and Management

Pharmacological Interventions

Pharmacological interventions for emotional lability primarily target underlying neurochemical imbalances to reduce the frequency and intensity of involuntary emotional outbursts. Selective serotonin reuptake inhibitors (SSRIs), such as and sertraline, are commonly prescribed to stabilize serotonin levels in the , which helps modulate emotional regulation and decrease episode frequency in conditions like post-stroke emotionalism. For instance, at 20 mg/day has demonstrated efficacy in reducing pathological crying and laughing, with one showing that 50% of treated patients achieved at least a 50% reduction in emotional outbursts compared to 10% on . Similarly, sertraline at doses of 50-100 mg/day has been associated with significant improvements in tearfulness and lability scale scores across multiple studies, including a Cochrane review of three trials involving 164 participants that reported a of 2.18 for diminished tearfulness (95% CI 1.29-3.71). For emotional lability associated with (PBA), a specific form involving incongruent laughing or episodes, the combination of and quinidine (e.g., Nuedexta) is FDA-approved since 2010 as the only . This formulation works by inhibiting NMDA receptors and sigma-1 agonism via , with quinidine preventing its rapid to enhance and effects on emotional pathways. Clinical trials support its efficacy; in a 125-patient study, (30 mg/30 mg twice daily) led to a 52% rate of symptom-free status after 30 days, versus 23% with alone and 12% with quinidine alone, as measured by the Center for Neurologic Study-Lability Scale (CNS-LS). An trial with 150 patients showed a 46% reduction in PBA episodes over 85 days compared to . In cases of emotional lability comorbid with , anticonvulsants like are utilized for mood stabilization to address affective instability. , typically dosed at 100-200 mg/day, exerts its effects through modulation and glutamate release inhibition, helping to prevent rapid mood shifts and . In post-stroke contexts with lability, case reports have shown rapid resolution of pathological laughing and crying with initiation. These interventions are often integrated with non-pharmacological therapy for optimal management.

Non-Pharmacological Approaches

Non-pharmacological approaches to managing emotional lability emphasize psychological, behavioral, and environmental strategies aimed at enhancing emotional regulation and reducing the frequency and intensity of mood swings. These interventions focus on building skills to identify emotional triggers, foster adaptive mechanisms, and create supportive contexts that mitigate distress without relying on medications. Such strategies are particularly valuable for individuals with neurological or psychiatric underpinnings of emotional lability, as they promote long-term self-management and can be tailored to specific contexts like post-stroke recovery or mood disorders. Cognitive behavioral therapy (CBT) is a cornerstone for emotional lability, involving structured techniques to help individuals recognize emotional triggers, reframe maladaptive thoughts, and develop scripts for episodes of lability. Therapists guide patients in monitoring mood fluctuations, challenging cognitive distortions that exacerbate instability, and practicing behavioral responses such as deep breathing or distraction during outbursts. A 2024 narrative review of interventions for highlights CBT's efficacy, reporting large effect sizes (Cohen's d = 1.25) for improving emotion regulation deficits and moderate reductions (d = 0.28) in overall emotional dysregulation symptoms across diverse populations, including those with brain injuries and psychiatric conditions. Systematic analyses of 67 studies confirm these benefits, with CBT enhancing emotional awareness and clarity, thereby decreasing distress in non-neurological cases by facilitating adaptive responses to triggers. Mindfulness and relaxation training offer complementary tools for emotional lability by cultivating present-moment awareness and physiological calm to interrupt rapid mood shifts. (MBIs), such as guided and body scans, train individuals to observe emotions non-judgmentally, reducing reactive lability, while relaxation techniques like or () promote balance. In at-risk youth with mood lability, an 8-week MBI increased mindfulness levels and reduced lability scores (F=7.2, p=.002), with evidence of strengthened connectivity in networks supporting . A 2024 systematic review supports MBIs' role in enhancing distress tolerance and emotional when integrated with , particularly for anxiety-linked lability. Similarly, HRV yields small-to-medium effects (Hedges' g = 0.34) on reducing by improving stress recovery and relaxation responses, as evidenced in meta-analyses of 58 randomized controlled trials. Supportive interventions, including family education programs and workplace accommodations, address the social and environmental factors influencing emotional lability. Family education equips caregivers with strategies to validate emotions, avoid reinforcement of outbursts, and model skills, thereby reducing secondary distress and improving household dynamics. Reviews of pediatric management indicate that parent training programs decrease lability as a secondary outcome by bolstering family-level regulation. Group-based supportive therapies foster peer understanding and shared , achieving large sizes in skill-building for emotional control, per analyses of 15 studies. Workplace accommodations, such as flexible scheduling or quiet spaces, minimize triggers in professional settings. These approaches can complement pharmacological treatments in severe cases for holistic management.

Epidemiology and Prognosis

Prevalence and Demographics

Emotional lability, often manifesting as uncontrolled laughing or crying disproportionate to the stimulus, affects approximately 10-20% of survivors, with prevalence rates reported as high as 20% six months post-event. In patients with (), the condition is more frequent, impacting up to 45-50% depending on diagnostic thresholds for associated . Demographically, emotional lability is associated with neurological conditions that increase in prevalence among adults over 50 years old, such as and that underpin the disorder. However, among survivors, younger age has been identified as a . Gender distribution appears relatively equal overall, though studies indicate higher rates in females, potentially linked to hormonal influences in conditions like . Post-2020, there has been growing recognition of emotional lability in (TBI) cases, driven by improved diagnostic tools and increased awareness from sports-related and accidental injuries. Globally, reported rates are higher in developed countries with aging populations, where neurological disorders are more commonly diagnosed and studied.

Long-Term Outlook

The long-term outlook for emotional lability varies significantly based on its underlying etiology. In cases associated with , symptoms often improve or resolve with appropriate treatment and time, with studies showing that antidepressants like can achieve at least a 50% reduction in crying episodes in a majority of affected patients. In contrast, when linked to progressive neurodegenerative conditions such as (ALS), emotional lability tends to persist chronically and may accelerate disease progression, as evidenced by faster declines in functional scores among those exhibiting symptoms at onset. Several key factors influence the , including the timing of , the reversibility of the causative condition, and the of co-occurring issues. Early pharmacological or therapeutic interventions, such as selective serotonin inhibitors, can substantially mitigate and , particularly in treatable causes like post-stroke lability. Outcomes are more favorable when the underlying neurological damage is addressable, whereas progressive disorders limit recovery potential; additionally, addressing comorbid through integrated psychological support enhances overall emotional stability. If left unmanaged, emotional lability can lead to serious complications, including chronic due to from uncontrollable episodes and an elevated risk of developing or exacerbating , which further impairs daily functioning and . Recent 2025 underscores the benefits of integrated approaches in improving long-term outcomes. For instance, audio-visual entrainment therapy has demonstrated significant reductions in symptoms—equivalent to 36-52% decreases in standardized lability scores—with sustained improvements in episode frequency and observed at three-month follow-up. Similarly, a study of patients with primary lateral sclerosis found that emotional lability episodes, occurring daily in 43% of cases, profoundly affect social interactions and overall , highlighting the value of comprehensive management to reduce such impacts over time.

Pseudobulbar Affect

(PBA) is a distinct neurological and subtype of emotional lability, characterized by sudden, involuntary, and uncontrollable episodes of laughing or that occur disproportionately to or incongruently with the individual's actual or situation. These outbursts result from disruption in the neural pathways controlling , specifically due to lesions in the upper motor neurons of the corticobulbar tracts. PBA is not a reflection of the patient's true emotional state but rather a pathological release of secondary to neurological , distinguishing it as a motor rather than a primary psychiatric . The primary causes of PBA involve bilateral damage to the corticobulbar tracts, which connect the to the nuclei controlling facial and laryngeal muscles. Common underlying conditions include , (MS), (TBI), and amyotrophic lateral sclerosis (ALS), where such damage impairs the inhibition of emotional reflexes. Episodes typically last seconds to minutes, occur frequently (often multiple times daily), and may be accompanied by unique neurological signs such as (slurred speech), , or , further indicating the organic basis of the syndrome. Unlike general emotional lability, PBA episodes are strictly incongruent with internal mood and lack voluntary control, often leading to social embarrassment or distress for affected individuals. Diagnosis of PBA relies on clinical and validated tools, with the Center for Neurologic Study-Lability Scale (CNS-LS) serving as a specific, self-administered tailored for this condition. The CNS-LS consists of seven items assessing the and impact of laughing or crying episodes, with total scores ranging from 7 to 35; scores of 13 or higher indicate probable PBA, while scores of 21 or above suggest greater severity. This scale has been validated in populations with and other neurological disorders, correlating well with episode observed by clinicians. Treatment centers on pharmacological intervention, with Nuedexta (dextromethorphan 20 mg/quinidine 10 mg) as the first-line and FDA-approved therapy, which enhances serotonin and glutamate modulation to reduce emotional disinhibition. Clinical trials, including a 12-week double-blind study in patients with ALS or , demonstrated that Nuedexta reduced PBA episode rates by 47-49% compared to , with significant improvements in measures.

Distinctions from Similar Disorders

Emotional lability is characterized by rapid, excessive, and often stimulus-driven shifts in mood that occur in response to situational triggers, distinguishing it from the endogenous, cyclical mood episodes typical of , where manic or depressive phases follow a more autonomous pattern unrelated to immediate external stimuli. In , these cycles can last days to months and involve profound elevations or depressions in mood, whereas emotional lability manifests as brief, intense reactions that resolve quickly once the stimulus subsides. Unlike (), where emotional lability serves as one feature amid a broader pattern including , intense fear of abandonment, and unstable interpersonal relationships, isolated emotional lability does not encompass these pervasive relational and impairments central to diagnosis. In , mood instability is intertwined with these core elements, often leading to or , whereas emotional lability alone lacks this relational volatility and is more narrowly tied to affective reactivity without the full syndromal context of . Emotional lability differs from in , which features a persistent low with overlaid or rather than the rapid, bidirectional fluctuations between positive and negative affects seen in lability. Depressive tends to sustain a negative emotional tone over extended periods, contributing to overall and hopelessness, in contrast to the volatile, short-lived shifts in emotional lability that can include sudden positive responses. A primary differentiator lies in the underlying basis: emotional lability often stems from neurological disruptions, such as those in following brain injury, whereas personality disorders like are primarily rooted in psychological and developmental factors involving maladaptive emotion regulation patterns. Additionally, treatment responses vary, with emotional lability in neurological contexts showing limited benefit from antidepressants, which are more effective for mood stabilization in psychiatric disorders but less so for the core affective instability in personality disorders beyond comorbid .

References

  1. [1]
    Emotional lability (Concept Id: C0085633) - NCBI
    Unstable emotional experiences and frequent mood changes; emotions that are easily aroused, intense, and/or disproportionate to events and circumstances.
  2. [2]
    Emotional Lability: Mood Swings, Strong Feelings, and More - WebMD
    Sep 23, 2024 · Emotional lability is characterized by rapid exaggerated changes in mood. You'll feel strong emotions and feel like you can't control your behavior and ...
  3. [3]
    Understanding emotional lability: Causes, symptoms, and getting help
    Oct 10, 2023 · Emotional lability involves rapid mood changes when strong emotions occur. This may cause uncontrollable laughing and crying or increased temper or ...
  4. [4]
    Real‐time assessment of positive and negative affective fluctuations ...
    Nov 3, 2022 · Emotional lability, defined as rapid and/or intense affect fluctuations, is associated with pediatric psychopathology.
  5. [5]
    Emotional Lability Independently Predicts Functional Impairment in ...
    Sep 10, 2025 · Emotional lability (EL) generally describes exaggerated emotional responses that are disproportionate to the situation, abrupt and unpredictable ...
  6. [6]
    Evolving models of pseudobulbar affect: historical accounts ...
    The first account of “emotional lability” in ALS was reported by Pierre Marie in 1892. Since the earliest descriptions of PCL, there has been a lack of ...
  7. [7]
    Diagnosis and Management of Pathological Laughter and Crying
    The authors labeled these patients as having “emotional lability,” which they defined as “pathological laughing and crying with an underlying mood disorder.”.
  8. [8]
    The Contribution of Sensory Sensitivity to Emotional Lability in ... - NIH
    Although operational definitions of emotional lability vary, the term generally refers to emotional reactions that are out of proportion to the situation, ...Abstract · Results · Discussion<|control11|><|separator|>
  9. [9]
    Pathological Crying and Laughing in Motor Neuron Disease - Frontiers
    The terms “pathological crying and laughing,” “pseudobulbar affect,” “emotional lability,” and “involuntary emotional expression disorder” are often used ...
  10. [10]
    Emotional Incontinence - an overview | ScienceDirect Topics
    Other terms encountered in the medical literature to describe PLC include pseudobulbar affect, emotional incontinence, and involuntary emotional expression ...<|control11|><|separator|>
  11. [11]
    Emotional Lability as a Symptom of Extra-axial Posterior Fossa Tumors
    Emotional lability (EL), the uncontrollable and unmotivated expression of emotion, is a rare and distressing symptom of brainstem compression.Missing: definition | Show results with:definition
  12. [12]
    Affective Instability: Impact of Fluctuating Emotions on Regulation ...
    Sep 6, 2024 · A key aspect of affective instability, affective lability, refers to the excessive and unpredictable deviations from one's emotional baseline [1] ...
  13. [13]
    Characterization of affective lability across subgroups of psychosis ...
    Nov 4, 2021 · The construct of affective lability refers to the propensity to experience rapid, unpredictable and excessive changes in affective states ( ...
  14. [14]
    The epidemiology and pathophysiology of pseudobulbar affect and ...
    May 27, 2013 · The emotional lability questionnaire is an adaptation of the PLACS for use specifically in ALS., It has not been validated in other ...
  15. [15]
    Pseudobulbar Affect in Parkinsonian Disorders: A Review - PMC - NIH
    Pseudobulbar affect (PBA) is a neurological symptom of inappropriate and uncontrollable laughter or crying that occurs secondary to a variety of neurological ...
  16. [16]
    Affective lability and social functioning in severe mental disorders
    Affective lability refers to the propensity to experience rapid, excessive and unpredictable changes in affective states and is associated with poor clinical ...Methods · Statistical Analyses · Results
  17. [17]
    Emotional Lability Independently Predicts Functional Impairment in ...
    Sep 10, 2025 · EL, along with attention scores, social problems, and delinquent behaviors, significantly predicted the overall functional impairment.
  18. [18]
    Emotional dysfunction as a marker of bipolar disorders - PMC
    We found that affective intensity and lability of emotions in response to daily life events were markedly higher in euthymic bipolar subjects (n=179) than ...
  19. [19]
    Borderline personality disorder: a comprehensive review of ...
    Jan 12, 2024 · Emotional lability: Unstable emotional experiences and frequent mood changes; emotions that are easily aroused, intense and/or out of ...
  20. [20]
    Emotion dysregulation in ADHD and other neurodevelopmental ...
    Nov 28, 2022 · Around 25–45% of children and 30–70% of adults with ADHD also have difficulties regulating emotions, resulting in more severe outcomes [4,5,6,7] ...
  21. [21]
    Emotional Lability and Affective Synchrony in Posttraumatic Stress ...
    This study examined the relations of PTSD pathology to both the lability of three specific emotions (anxiety, anger, self-conscious emotions [SCE])Missing: definition | Show results with:definition
  22. [22]
    Perimenopause and First-Onset Mood Disorders: A Closer Look
    Aug 18, 2021 · Perimenopause is often a time of social, emotional, and physical change. Various factors contribute to the development of mood disorders during this time.
  23. [23]
    Neuropsychiatric Manifestations of Thyroid Diseases - PMC
    Forgetfulness, mental sluggishness, lethargy, and emotional lability are common signs of psychological dysfunction in hypothyroidism. It's usual to have ...
  24. [24]
    Alcohol Withdrawal and the Associated Mood Disorders—A Review
    As such, naltrexone is approved for use in treating ethanol dependence and addiction in conjunction with other non-pharmacological measures such as psychosocial ...<|control11|><|separator|>
  25. [25]
    Chapter 3—Medical Aspects of Stimulant Use Disorders - NCBI
    Postacute withdrawal or “the wall.” This period is characterized by a profound hypersomnolence, fatigue, mood lability, and increased appetite. People ...Missing: emotional | Show results with:emotional
  26. [26]
    A Longitudinal Study of Emotion Regulation, Emotion Lability ...
    Early maltreatment was associated with high emotion lability/negativity (age 7) that contributed to poor emotion regulation (age 8), which in turn was ...
  27. [27]
    Role of Serotonin and Dopamine System Interactions in the ...
    The review suggests that dysfunctional interactions between serotonin and dopamine systems in the prefrontal cortex may be an important mechanism underlying ...
  28. [28]
    Emotional dysregulation is part of ADHD. See how psychologists are ...
    Apr 1, 2024 · “We consistently see that about 25% of kids with ADHD have normative emotional expression, while the remaining 75% have some type of emotion ...
  29. [29]
    Genetics of emotion - PMC - PubMed Central - NIH
    Emotionality, measured as neuroticism, introversion or harm avoidance, is moderately to highly heritable in both sexes: 40-60%, with little effect of shared ...Missing: instability lability
  30. [30]
    Early life stress and development: potential mechanisms for adverse ...
    Dec 16, 2020 · The current paper reviews the existing literature on the neurobiological effects of early life stress and their ties to children's psychological and behavioral ...
  31. [31]
    Pseudobulbar affect - Symptoms and causes - Mayo Clinic
    May 16, 2018 · The primary sign of pseudobulbar affect (PBA) is frequent, involuntary and uncontrollable outbursts of crying or laughing that are exaggerated ...Overview · Symptoms · CausesMissing: lability | Show results with:lability
  32. [32]
    Neuropsychological correlates of emotional lability in children with ...
    Emotional lability (EL) is commonly seen in patients with Attention Deficit/Hyperactivity Disorder (ADHD). The reasons for this association are currently ...
  33. [33]
    Pseudobulbar Affect (PBA): Causes, Symptoms & Treatment
    PBA may be called several other names, including: Emotional lability. Pathological laughing and crying. Involuntary emotional expression disorder. Compulsive ...
  34. [34]
    Emotional Dysregulation in Children and Adolescents With ...
    Emotional dysregulation (ED) is a transdiagnostic construct defined as the inability to regulate the intensity and quality of emotions.
  35. [35]
    Borderline Personality Disorder - StatPearls - NCBI Bookshelf
    Borderline personality disorder (BPD) is a mental health condition characterized by pervasive patterns of instability in mood, self-image, and interpersonal ...
  36. [36]
    Pseudobulbar Palsy - StatPearls - NCBI Bookshelf
    Magnus reported the first case of pseudobulbar palsy in 1837 in a patient having multiple infarcts. Lepine, in 1877 introduced the term pseudobulbar palsy ...
  37. [37]
    Pseudobulbar affect: the spectrum of clinical presentations ...
    Jan 9, 2014 · Moreover, PBA and other disorders of affect are not included in DSM-based diagnostic criteria or International Classification of Diseases ...
  38. [38]
    Diagnosing pseudobulbar affect in traumatic brain injury - PMC
    Pseudobulbar affect (PBA) is defined by episodes of involuntary crying and/or laughing as a result of brain injury or other neurological disease.
  39. [39]
    Diagnosing pseudobulbar affect in traumatic brain injury | NDT
    Oct 7, 2014 · Pseudobulbar affect (PBA) is defined by episodes of involuntary crying and/or laughing as a result of brain injury or other neurological disease.<|control11|><|separator|>
  40. [40]
    Pseudobulbar Affect Versus Depression: Issues in Diagnosis and ...
    Jul 31, 2018 · This disorder was previously called emotional incontinence, pathological crying, and emotional lability. A likely reference to PBA appeared in ...
  41. [41]
    A self report measure of affective lability - PubMed
    The CNS-LS is a short, easily administered, and psychometrically sound measure of affective lability for use with patients with ALS.
  42. [42]
    Validation of the CNS emotional lability scale for pseudobulbar ...
    The objective of this study was to validate the CNS Emotional Lability Scale (CNS-LS) in MS patients and to correlate the results with the frequency and ...<|control11|><|separator|>
  43. [43]
    Pseudobulbar affect - MedLink Neurology
    Pathologic laughter, often associated with crying, is also referred to as pseudobulbar affect and can occur as a part of emotional incontinence in ...<|control11|><|separator|>
  44. [44]
    [PDF] Screening for Pseudobulbar Affect in an Outpatient Mental Health ...
    May 21, 2018 · A total score of ≥13 has been recommended as a cutoff for a possible clinical diagnosis of PBA.Missing: threshold | Show results with:threshold
  45. [45]
    Pharmaceutical interventions for emotionalism after stroke - PMC
    Disturbances of emotional behaviour, such as difficulty controlling crying or laughing, are common after stroke (House 1989). Poeck 1969 distinguished two main ...
  46. [46]
    [PDF] NUEDEXTA (dextromethorphan hydrobromide and quinidien sulfate)
    NUEDEXTA is indicated for the treatment of pseudobulbar affect (PBA). PBA occurs secondary to a variety of otherwise unrelated neurologic conditions, and is ...
  47. [47]
    Dextromethorphan/quinidine sulfate (Zenvia) for Pseudobulbar Affect
    Two recent trials have indicated that a new agent consisting of a combination of dextromethorphan and quinidine (DM/Q) is effective in treating PBA due to ALS ...Introduction · Treatment · Selective Serotonin Reuptake...
  48. [48]
    Evaluating the use of lamotrigine to reduce mood lability and ... - NIH
    Mar 17, 2022 · Findings provide initial data suggesting that lamotrigine could be useful as an adjunctive treatment for patients with affective lability and impulsivity.
  49. [49]
    Lamotrigine Treatment for Post-Stroke Pathological Laughing and ...
    Aug 7, 2025 · Serial trial of SSRIs and dextromethorphan/quinidine could not help until risperidone, an antipsychotic was introduced with resolution of ...
  50. [50]
    A Narrative Review of the Efficacy of Interventions for Emotional ...
    As summarized in more details below, the most used and effective non-pharmacological interventions for ED (especially, for adults) are cognitive behavioral ...
  51. [51]
  52. [52]
    Mindfulness-Based Intervention to Decrease Mood Lability in At ...
    Mindfulness-based interventions (MBI) may improve emotion regulation, in part by increasing resting-state functional connectivity (rsFC) between posterior ...
  53. [53]
  54. [54]
  55. [55]
    Post-stroke emotionalism: Diagnosis, pathophysiology, and treatment
    Factors predisposing emotionalism include female gender, younger age, and previous neurological condition. Several stroke characteristics have been identified ...
  56. [56]
    Pseudobulbar affect: Prevalence and association with symptoms in ...
    Using CNS-LS scores ≥13 and ≥21, the prevalence of PBA in MS patients was 45.8% and 12.0%, respectively; the cutoff ≥17 was not applied. No evaluation of ...
  57. [57]
    Post-stroke emotionalism: Diagnosis, pathophysiology, and treatment
    Mar 19, 2024 · Factors predisposing emotionalism include female gender, younger age, and previous neurological condition. ... Emotional lability after stroke.
  58. [58]
    Pseudobulbar affect (pathological laughing and crying) - MS Trust
    Apr 1, 2022 · This scale has been validated for use in people with MS, where a score of 17 or more would indicate PBA. The Pathological Laughter and Crying ...Missing: threshold | Show results with:threshold
  59. [59]
    Mood Disorders Following Traumatic Brain Injury
    Apr 10, 2023 · The most common mood disorders after TBI are major depressive disorder and anxiety disorders, with prevalence ranges of 13% to 53% and 11% to 70%, respectively.Missing: trends | Show results with:trends
  60. [60]
    Mental health of older adults - World Health Organization (WHO)
    Oct 8, 2025 · Mental disorders among older adults aged 70 years or older account for 6.8% of the total years lived with disability for this age group.Missing: lability | Show results with:lability
  61. [61]
    Citalopram for post-stroke pathological crying - ScienceDirect.com
    In 13 patients in whom frequency of crying could be assessed, the number of daily crying episodes decreased by at least 50% in all cases during citalopram ...Missing: percentage | Show results with:percentage
  62. [62]
    Emotional Lability at Disease Onset Is an Independent Prognostic ...
    The mechanism of EL remains unclear, as it probably involves damage of motor and temporal cortex and the disinhibition of brainstem and a putative centre for ...
  63. [63]
    Pathological Laughing and Crying Post-stroke: Liaison Psychiatrist ...
    Pathological laughing and crying has been known by a number of different names, but the most widely used terms are “pseudobulbar affect,” “emotional lability,” ...<|separator|>
  64. [64]
    Poststroke Depression: An Update | The Journal of Neuropsychiatry ...
    Aug 10, 2023 · SSRIs, the most frequently studied antidepressants, improved neurobehavioral outcomes by 52% (95% CI=39–65) (55) (SR28 and SR29, online ...
  65. [65]
    Pseudobulbar Affect - Home Healthcare Now
    Lack of recognition and ineffective or insufficient treatment often lead to poor quality of life with an increased incidence of social isolation, depression, ...
  66. [66]
    Audio-Visual Entrainment (AVE) Therapy in Reducing Symptoms of ...
    Mar 24, 2025 · AVE therapy effectively reduces PBA symptoms, demonstrating lasting benefits at a 3-month follow-up. This study supports AVE as a promising ...
  67. [67]
    Pseudobulbar affect: clinical associations, social impact and quality ...
    Mar 12, 2025 · The impact of PBA was significantly correlated with the burden of symptomatic crying and not with that of laughing. This finding is perhaps not ...
  68. [68]
    Pseudobulbar affect: prevalence and management - PMC - NIH
    Nov 29, 2013 · Pseudobulbar affect (PBA) is characterized by uncontrolled crying or laughing which may be disproportionate or inappropriate to the social context.Pathophysiology · Treatment · General Principles<|separator|>
  69. [69]
    Validation of the CNS emotional lability scale for pseudobulbar ...
    The objective of this study was to validate the CNS Emotional Lability Scale (CNS-LS) in MS patients and to correlate the results with the frequency and ...
  70. [70]
    Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA ...
    Jun 17, 2014 · For both DM/Q doses, the rate was significantly lower than for placebo, by 46.9% for DM/Q 30/10 mg and by 49.0% for DM/Q 20/10 mg.
  71. [71]
    Affective instability and the course of bipolar depression - NIH
    Individuals who are affectively unstable are often emotionally reactive to situational stimuli and have an attenuated ability to regulate their emotions.<|separator|>
  72. [72]
    Neurobiology of bipolar disorders: a review of genetic components ...
    Bipolar disorder (BD) is a chronic mental illness characterized by changes in mood that alternate between mania and hypomania or between depression and mixed ...Missing: lability | Show results with:lability
  73. [73]
    Components of Emotion Dysregulation in Borderline Personality ...
    We conceptualize emotion dysregulation in borderline personality disorder (BPD) as consisting of four components: emotion sensitivity, heightened and labile ...Emotion Sensitivity · Negative Affect · Inadequate Emotion...<|separator|>
  74. [74]
    Mood Instability and Irritability as Core Symptoms of Major Depression
    Oct 26, 2016 · Mood instability and irritability are candidate core symptoms of the depressive syndrome and should be part of its clinical assessment.
  75. [75]
    How and why are irritability and depression linked? - PubMed Central
    Tonic irritability refers to persistently angry, grumpy, or grouchy mood, usually lasting days and weeks. Phasic irritability refers to behavioral outbursts of ...
  76. [76]
    Borderline personality disorder: current drug treatments and future ...
    Overall, meta-analysis provides little evidence to support the use of antidepressant medication in BPD outside episodes of major depression. However, there is ...
  77. [77]
    Pharmacological Management of Borderline Personality Disorder ...
    31 May 2023 · In short, in patients with BPD and comorbid MDD, antidepressant treatment should only be offered as an adjunct to psychological therapy. ...